Published in Circ Res on January 17, 2008
Atherosclerosis: current pathogenesis and therapeutic options. Nat Med (2011) 4.95
Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci U S A (2011) 1.62
Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest (2012) 1.57
Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol (2013) 1.48
The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction. J Immunol (2010) 1.42
Innate and adaptive immunity in atherosclerosis. Semin Immunopathol (2009) 1.40
Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res (2009) 1.37
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol (2011) 1.26
Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol (2012) 1.18
Dendritic cells in atherosclerotic disease. Clin Immunol (2009) 1.17
Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation (2011) 1.12
T cells in arteritis and atherosclerosis. Curr Opin Lipidol (2008) 1.10
Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases. Ophthalmology (2009) 1.08
Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Front Physiol (2012) 1.04
Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol Genomics (2011) 1.01
Giant cell arteritis: immune and vascular aging as disease risk factors. Arthritis Res Ther (2011) 0.95
Vascular damage in giant cell arteritis. Autoimmunity (2009) 0.95
Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells. PLoS One (2014) 0.92
The adventitia: Essential role in pulmonary vascular remodeling. Compr Physiol (2011) 0.85
Decreased regulatory T cells in vulnerable atherosclerotic lesions: imbalance between pro- and anti-inflammatory cells in atherosclerosis. Mediators Inflamm (2015) 0.81
Giant cell arteritis: dendritic cells take two T's to tango. Circ Res (2009) 0.80
Emergence of dendritic cells in the myocardium after acute myocardial infarction - implications for inflammatory myocardial damage. Int J Biomed Sci (2010) 0.79
[Pathogenesis of medium- and large-vessel vasculitis]. Z Rheumatol (2009) 0.78
Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis. Joint Bone Spine (2016) 0.78
Giant Cell Arteritis: From Pathogenesis to Therapeutic Management. Curr Treatm Opt Rheumatol (2016) 0.77
[Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists]. Pathologe (2012) 0.77
CD4+ T cells sensitized by vascular smooth muscle induce vasculitis, and interferon gamma is critical for the initiation of vascular pathology. Am J Pathol (2010) 0.75
Innate immune cells in the pathogenesis of primary systemic vasculitis. Rheumatol Int (2015) 0.75
Immune Checkpoint Dysfunction in Medium and Large Vessel Vasculitis. Am J Physiol Heart Circ Physiol (2017) 0.75
The influence of age on T cell generation and TCR diversity. J Immunol (2005) 4.36
Medium- and large-vessel vasculitis. N Engl J Med (2003) 3.96
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med (2007) 3.81
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum (2006) 3.64
Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med (2003) 3.48
Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med (2014) 3.46
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
T cell subset-specific susceptibility to aging. Clin Immunol (2008) 2.42
T cell development and receptor diversity during aging. Curr Opin Immunol (2005) 2.29
Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol (2004) 2.28
The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol (2012) 2.19
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med (2012) 2.19
Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials (2004) 2.12
Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 2.09
Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 2.08
Aging and T-cell diversity. Exp Gerontol (2007) 2.06
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med (2013) 1.96
Rheumatoid arthritis. Immunol Rev (2005) 1.94
Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation (2008) 1.91
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum (2005) 1.88
Th17 and Th1 T-cell responses in giant cell arteritis. Circulation (2010) 1.88
Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum (2002) 1.80
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation (2006) 1.77
Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res (2006) 1.77
BLyS and APRIL in rheumatoid arthritis. J Clin Invest (2005) 1.75
Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med (2011) 1.73
T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation (2002) 1.72
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med (2004) 1.70
Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture. Exp Cell Res (2003) 1.69
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation (2010) 1.68
Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol (1985) (2005) 1.68
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65
T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res (2006) 1.62
Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood (2009) 1.62
Homeostatic control of T-cell generation in neonates. Blood (2003) 1.62
Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther (2003) 1.61
Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J (2005) 1.56
Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest (2015) 1.55
Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A (2009) 1.54
Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med (2009) 1.54
NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs. J Clin Invest (2016) 1.53
Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng (2003) 1.52
Prevalence and clinical implication of metabolic syndrome in chronic heart failure. Circ J (2010) 1.51
Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann Biomed Eng (2003) 1.49
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med (2006) 1.48
Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol (2013) 1.48
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med (2004) 1.47
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation (2007) 1.47
Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol (2006) 1.42
Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: influence of shear stress. Arterioscler Thromb Vasc Biol (2005) 1.41
Effects of Phase II Comprehensive Cardiac Rehabilitation on Coronary Plaque Volume After Acute Coronary Syndrome. Int Heart J (2015) 1.40
Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis (2004) 1.39
Prognostic Impacts of Metabolic Syndrome in Patients With Chronic Heart Failure - A Multicenter Prospective Cohort Study. Circ J (2016) 1.39
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther (2005) 1.38
T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol (2004) 1.38
Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther (2009) 1.38
A global assessment of stem cell engineering. Tissue Eng Part A (2014) 1.38
Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol (2003) 1.38
CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med (2002) 1.38
Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res (2009) 1.37
Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng (2006) 1.36
Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol (2006) 1.34
Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol (2003) 1.33
Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.29
A biological hybrid model for collagen-based tissue engineered vascular constructs. Biomaterials (2003) 1.26
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26